JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd

₹ 16.2 3.86%
28 Mar - close price
About

Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing of
oral and dental products for national and international brands[1]

Key Points

Business Overview:[1]
JHSSLL manufactures Toothbrushes, Toothpastes, Mouthwash and Denture Tablets. Apart from working on its own brands viz. Dr. Gold, Aquawhite, etc. company also offers Contract Manufacturing Partnership to brands in domestic and international markets

  • Market Cap 127 Cr.
  • Current Price 16.2
  • High / Low 39.5 / 14.0
  • Stock P/E 21.5
  • Book Value 21.8
  • Dividend Yield 0.00 %
  • ROCE -0.42 %
  • ROE 1.87 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Stock is trading at 0.74 times its book value
  • Debtor days have improved from 125 to 81.0 days.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -9.93% over past five years.
  • Promoter holding is low: 37.7%
  • Company has a low return on equity of 0.66% over last 3 years.
  • Promoter holding has decreased over last 3 years: -6.44%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: FMCG Industry: Personal Care - Indian

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
25.53 24.96 20.25 23.06 19.34 17.25 19.20 21.05 22.19 20.60 15.90 18.93 14.30
23.41 24.35 20.48 22.21 19.49 17.54 20.15 23.02 24.41 23.96 18.02 18.52 14.35
Operating Profit 2.12 0.61 -0.23 0.85 -0.15 -0.29 -0.95 -1.97 -2.22 -3.36 -2.12 0.41 -0.05
OPM % 8.30% 2.44% -1.14% 3.69% -0.78% -1.68% -4.95% -9.36% -10.00% -16.31% -13.33% 2.17% -0.35%
0.38 3.24 2.27 1.44 2.42 2.01 1.19 2.52 0.94 -11.05 0.41 0.20 2.34
Interest 0.10 0.13 0.10 0.12 0.13 0.14 0.12 0.12 0.16 0.08 0.13 0.10 0.11
Depreciation 1.41 1.36 1.45 1.51 1.50 1.44 1.41 1.49 1.46 1.57 1.32 1.50 1.63
Profit before tax 0.99 2.36 0.49 0.66 0.64 0.14 -1.29 -1.06 -2.90 -16.06 -3.16 -0.99 0.55
Tax % 49.49% -16.53% 30.61% 33.33% 28.12% 2,728.57% -157.36% 13.21% 4.83% 41.22% 18.35% 26.26% 98.18%
0.51 2.75 0.33 0.45 0.46 -3.69 -3.32 -0.92 -2.76 -9.44 -2.59 -0.73 0.01
EPS in Rs 0.08 0.43 0.05 0.07 0.07 -0.57 -0.51 -0.14 -0.43 -1.45 -0.40 -0.09 0.00
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
93 56 35 55 100 104 138 120 133 97 80 82 70
81 44 39 59 93 92 122 111 123 93 80 90 75
Operating Profit 11 12 -4 -4 7 12 17 8 9 4 0 -8 -5
OPM % 12% 21% -11% -7% 7% 11% 12% 7% 7% 4% 0% -10% -7%
1 12 -3 -6 -17 0 32 5 1 6 8 -6 -8
Interest 6 10 14 0 0 1 1 1 1 0 0 0 0
Depreciation 7 14 15 12 10 6 7 7 7 6 6 6 6
Profit before tax -2 -0 -35 -22 -22 5 41 5 2 3 2 -20 -20
Tax % -143% -2,907% 18% -0% 0% -326% 32% 31% 1% 13% 228% 23%
-4 -4 -29 -22 -22 22 28 4 2 3 -2 -15 -13
EPS in Rs -2.07 -1.75 -11.95 -9.19 -5.75 4.98 4.61 0.59 0.29 0.43 -0.38 -2.33 -1.94
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 4%
5 Years: -10%
3 Years: -15%
TTM: -13%
Compounded Profit Growth
10 Years: 9%
5 Years: -19%
3 Years: -32%
TTM: 155%
Stock Price CAGR
10 Years: 10%
5 Years: -10%
3 Years: -6%
1 Year: 17%
Return on Equity
10 Years: 1%
5 Years: 2%
3 Years: 1%
Last Year: 2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 18 24 24 24 38 44 61 61 61 64 65 65 78
Reserves 82 50 21 78 57 86 116 119 121 127 125 110 93
67 102 54 19 2 2 2 7 3 2 2 2 2
42 41 74 33 25 23 26 33 46 21 19 37 24
Total Liabilities 208 217 173 153 123 156 205 220 230 215 211 213 197
52 135 121 108 65 65 71 69 58 59 55 64 69
CWIP 24 0 0 0 1 1 0 5 7 9 16 4 5
Investments 0 0 0 0 0 1 18 15 17 14 15 16 3
131 81 52 46 57 89 116 130 148 133 125 129 120
Total Assets 208 217 173 153 123 156 205 220 230 215 211 213 197

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-11 60 28 7 -6 -4 13 -10 15 15 -11 20
-26 -23 3 1 4 -3 -27 1 -7 -6 -1 9
37 -40 -29 -10 4 10 14 4 -8 6 0 -1
Net Cash Flow -0 -2 2 -1 2 3 0 -5 -0 16 -12 29

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 319 160 60 82 25 48 113 171 262 221 74 81
Inventory Days 77 155 122 94 53 96 59 51 19 76 104 126
Days Payable 197 478 95 106 67 125 123 134 179 126 147 237
Cash Conversion Cycle 199 -163 87 70 12 19 48 88 101 171 31 -30
Working Capital Days 216 -73 -548 -36 59 48 128 183 188 248 288 169
ROCE % 3% 1% -11% -14% -3% 5% 9% 4% 7% 2% 1% -0%

Shareholding Pattern

Numbers in percentages

4 Recently
Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
41.77% 41.77% 41.77% 41.77% 42.23% 42.23% 42.23% 42.23% 42.23% 42.23% 37.73% 37.73%
0.47% 0.39% 0.00% 0.04% 0.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9.16%
57.77% 57.84% 58.23% 58.20% 57.59% 57.77% 57.77% 57.78% 57.78% 57.78% 62.25% 53.10%
No. of Shareholders 20,01821,81725,37325,15524,75424,31724,30524,30823,96523,80022,79422,648

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls